학술논문

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study
Document Type
Article
Source
In ESMO Open February 2022 7(1)
Subject
Gynecologic Cancers
Language
ISSN
2059-7029